Anthera Pharmaceuticals, Inc. (ANTH)

[PennyMoocher69]

http://www.biopharmcatalyst.com/clinical-database/

Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for IgA Nephropathy

http://investor.anthera.com/releasedetail.cfm?ReleaseID=901728

Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company
Anthera to Form a New Subsidiary, Alkira Therapeutics, to Assume All Development Activities and Registration Activities as a Subsidiary of Anthera

http://investor.anthera.com/releasedetail.cfm?ReleaseID=859598

Anthera Pharmaceuticals Reports 2014 Fourth Quarter and Fiscal Year Financial Results, Operational Update and Recent Event Highlights
- CHABLIS-SC enrollment on track for completion in mid-2015, interim analysis completed
- Blisibimod autoimmune programs partnered with Zenyaku Kogyo Co., Ltd, Tokyo, Japan
- Sollpura (liprotamase) manufacturing agreement executed with Patheon for clinical product supply
- Eliminated all long-term debt

http://investor.anthera.com/releasedetail.cfm?ReleaseID=901716